SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Bergqvist M) srt2:(2015-2019)"

Sökning: WFRF:(Bergqvist M) > (2015-2019)

  • Resultat 1-10 av 29
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
1.
  • Francis, C. W., et al. (författare)
  • Treatment of venous thromboembolism in cancer patients with dalteparin for up to 12months : the DALTECAN Study
  • 2015
  • Ingår i: Journal of Thrombosis and Haemostasis. - : Elsevier BV. - 1538-7933 .- 1538-7836. ; 13:6, s. 1028-1035
  • Tidskriftsartikel (refereegranskat)abstract
    • BackgroundTreatment of venous thromboembolism (VTE) in patients with cancer has a high rate of recurrence and bleeding complications. Guidelines recommend low-molecular-weight heparin (LMWH) for at least 3-6months and possibly indefinitely for patients with active malignancy. There are, however, few data supporting treatment with LMWH beyond 6months. The primary aim of the DALTECAN study (NCT00942968) was to determine the safety of dalteparin between 6 and 12months in cancer-associated VTE. MethodsPatients with active cancer and newly diagnosed VTE were enrolled in a prospective, multicenter study and received subcutaneous dalteparin for 12months. The rates of bleeding and recurrent VTE were evaluated at months 1, 2-6 and 7-12. FindingsOf 334 patients enrolled, 185 and 109 completed 6 and 12months of therapy; 49.1% had deep vein thrombosis (DVT); 38.9% had pulmonary embolism (PE); and 12.0% had both on presentation. The overall frequency of major bleeding was 10.2% (34/334). Major bleeding occurred in 3.6% (12/334) in the first month, and 1.1% (14/1237) and 0.7% (8/1086) per patient-month during months 2-6 and 7-12, respectively. Recurrent VTE occurred in 11.1% (37/334); the incidence rate was 5.7% (19/334) for month 1, 3.4% (10/296) during months 2-6, and 4.1% (8/194) during months 7-12. One hundred and sixteen patients died, four due to recurrent VTE and two due to bleeding. ConclusionMajor bleeding was less frequent during dalteparin therapy beyond 6months. The risk of developing major bleeding complications or VTE recurrence was greatest in the first month of therapy and lower over the subsequent 11 months.
  •  
2.
  • Locht, Inka L. M., et al. (författare)
  • Standard model of the rare earths analyzed from the Hubbard I approximation
  • 2016
  • Ingår i: PHYSICAL REVIEW B. - : American Physical Society. - 2469-9950. ; 94:8
  • Tidskriftsartikel (refereegranskat)abstract
    • In this work we examine critically the electronic structure of the rare-earth elements by use of the so-called Hubbard I approximation. From the theoretical side all measured features of both occupied and unoccupied states are reproduced, without significant deviations between observations and theory. We also examine cohesive properties like the equilibrium volume and bulk modulus, where we find, in general, a good agreement between theory andmeasurements. In addition, we have reproduced the spin and orbital moments of these elements as they are reflected from measurements of the saturation moment. We have also employed the Hubbard I approximation to extract the interatomic exchange parameters of an effective spin Hamiltonian for the heavy rare earths. We show that the Hubbard I approximation gives results which are consistent with calculations where 4f electrons are treated as core states for Gd. The latter approach was also used to address the series of the heavy/late rare earths. Via Monte Carlo simulations we obtained ordering temperatures which reproduce measurements within about 20%. We have further illustrated the accuracy of these exchange parameters by comparing measured and calculated magnetic configurations for the heavy rare earths and the magnon dispersion for Gd. The Hubbard I approximation is compared to other theories of the electronic structure, and we argue that it is superior. We discuss the relevance of our results in general and how this makes it possible to treat the electronic structure of materials containing rare-earth elements, such as permanent magnets, magnetostrictive compounds, photovoltaics, optical fibers, topological insulators, and molecular magnets.
  •  
3.
  •  
4.
  •  
5.
  •  
6.
  •  
7.
  •  
8.
  •  
9.
  •  
10.
  • Anand, Kanwlajeet J. S., et al. (författare)
  • Assessment of continuous pain in newborns admitted to NICUs in 18 European countries
  • 2017
  • Ingår i: Acta Paediatrica. - : John Wiley & Sons. - 0803-5253 .- 1651-2227. ; 106:8, s. 1248-1259
  • Tidskriftsartikel (refereegranskat)abstract
    • Aim: Continuous pain occurs routinely, even after invasive procedures, or inflammation and surgery, but clinical practices associated with assessments of continuous pain remain unknown.Methods: A prospective cohort study in 243 Neonatal Intensive Care Units (NICUs) from 18 European countries recorded frequency of pain assessments, use of mechanical ventilation, sedation, analgesia, or neuromuscular blockade for each neonate upto 28 days after NICU admission.Results: Only 2113/6648 (31·8%) of neonates received assessments of continuous pain, occurring variably among tracheal ventilation (TrV, 46·0%), noninvasive ventilation (NiV, 35·0%), and no ventilation (NoV, 20·1%) groups (p<0·001). Daily assessments for continuous pain occurred in only 10·4% of all neonates (TrV: 14·0%, NiV: 10·7%, NoV: 7·6%; p<0·001). More frequent assessments of continuous pain occurred in NICUs with pain guidelines, nursing champions, and surgical admissions prompted (all p<0·01), and for newborns <32 weeks gestational age, those requiring ventilation, or opioids, sedatives-hypnotics, general anesthetics (O-SH-GA) (all p<0·001), or surgery (p=0·028). Use of O-SH-GA drugs increased the odds for pain assessment in the TrV (OR:1·60, p<0·001) and NiV groups (OR:1·40, p<0·001).Conclusion: Assessments of continuous pain occurred in less than one-third of NICU admissions, and daily in only 10% of neonates. NICU clinical practices should consider including routine assessments of continuous pain in newborns.
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 1-10 av 29
Typ av publikation
tidskriftsartikel (23)
konferensbidrag (6)
Typ av innehåll
refereegranskat (20)
övrigt vetenskapligt/konstnärligt (9)
Författare/redaktör
Jakobsson, PJ (5)
Bergqvist, M. (5)
Schwenk, Jochen M. (3)
Kogner, P (3)
Johnsen, JI (3)
Bjorkhem-Bergman, L (3)
visa fler...
Pontén, Fredrik (2)
Hoijer, J (2)
Hellström, Cecilia (2)
Dodig-Crnkovic, Tea (2)
Bergman, P. (2)
Berg, L (2)
Larsson, K (2)
Bergqvist, Michael (2)
Bergqvist, David (2)
Chen, T. (1)
Pais, R. (1)
Henriksson, R (1)
Edqvist, Per-Henrik ... (1)
Larsson, Rolf (1)
Gopalakrishnan, S. (1)
Abbas, Taimoor (1)
Tufvesson, Fredrik (1)
Gustafsson, Mats (1)
Björck, Martin (1)
Bäckhed, Fredrik, 19 ... (1)
Olsson, T (1)
Jagodic, M (1)
Johansson, E (1)
Debus, S (1)
Venermo, M (1)
Johansson, Börje (1)
Andonova, T (1)
Wickstrom, M (1)
Kultima, Kim (1)
Sundstrom, M (1)
Mitchell, D (1)
Benson, L (1)
Berglund, A. (1)
Lampa, J (1)
Lambe, M (1)
Nasic, Salmir (1)
Nordstrom, M (1)
Ponten, F. (1)
Lundberg, I (1)
Eriksson, Olle (1)
Gunnarsson, I (1)
Ståhle, Elisabeth (1)
Hesselager, Göran (1)
Nilsson, Mikael (1)
visa färre...
Lärosäte
Karolinska Institutet (16)
Uppsala universitet (8)
Kungliga Tekniska Högskolan (5)
Göteborgs universitet (3)
Örebro universitet (2)
Linnéuniversitetet (2)
visa fler...
Umeå universitet (1)
Lunds universitet (1)
RISE (1)
visa färre...
Språk
Engelska (29)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (12)
Naturvetenskap (2)
Teknik (1)
Samhällsvetenskap (1)

År

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy